Physician profile

Sidney Jonathan Starkman

Otolaryngology/Facial Plastic Surgery · Scottsdale, AZ

NPI 1881038966

$377.81

in general payments reported to CMS, 2019-2025

5 companies · $171 in 2025

The $171 reported for 2025 was less than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).

See the full distribution for Otolaryngology/Facial Plastic Surgery

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$216.32

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $184.12 2023-2025 Botox
Merz North America, INC. $77.07 2019
Allergan, INC. $60.35 2020-2022
Galderma Laboratories, L.P. $39.18 2019-2023
Hologic Sales and Service, LLC $17.09 2025 Coolseal Generator

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Sidney Jonathan Starkman

$377.81

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbvie INC.
Context
The $171 reported for 2025 was less than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).

https://glasscript.com/doctor/5704650/sidney-jonathan-starkman

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.